The function of CUB domain-containing protein 1 (CDCP1), a recently described transmembrane protein expressed on the surface of hematopoietic stem cells and normal and malignant cells of different tissue origin, is not well defined. The contribution of CDCP1 to tumor metastasis was analyzed by using HeLa carcinoma cells overexpressing CDCP1 (HeLa-CDCP1) and a high-disseminating variant of prostate carcinoma PC-3 naturally expressing high levels of CDCP1 (PC3-hi/diss). CDCP1 expression rendered HeLa cells more aggressive in experimental metastasis in immunodeficient mice. Metastatic colonization by HeLa-CDCP1 was effectively inhibited with subtractive immunization-generated, CDCP1-specific monoclonal antibody (mAb) 41-2, suggesting that CDCP...
CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a mar...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...
CUB domain containing protein 1 (CDCPl) is an integral membrane glycoprotein that has been implicate...
In the last few years dysregulated expression of the cell surface glycoprotein CUB domain-containing...
Background: Deregulated expression of the transmembrane glycoprotein CDCP1 (CUB domain-containing pr...
We report the application of quantitative mass spectrometry to identify plasma membrane proteins dif...
PURPOSE: Despite recent approvals for checkpoint inhibitors and antibody-drug conjugates targeting N...
The transmembrane glycoprotein, CUB (complement C1r/C1s, Uegf, Bmp1) domain-containing protein 1 (CD...
CUB Domain Containing Protein 1 (CDCP1) is a transmembrane glycoprotein that has mainly been implica...
Rationale: An antibody-drug conjugate (ADC) is a targeted therapy consisting of a cytotoxic payload ...
Background: CUB domain-containing protein 1 (CDCP1) is a cell surface receptor regulating key signal...
CUB domain-containing protein 1 (CDCP1) is a transmembrane protein that is highly expressed in stem ...
The prognosis of patients with advanced urothelial carcinoma (UC) remains poor and improving treatme...
Elevated CUB-domain containing protein 1 (CDCP1) is predictive of colorectal cancer (CRC) recurrence...
CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a mar...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...
CUB domain containing protein 1 (CDCPl) is an integral membrane glycoprotein that has been implicate...
In the last few years dysregulated expression of the cell surface glycoprotein CUB domain-containing...
Background: Deregulated expression of the transmembrane glycoprotein CDCP1 (CUB domain-containing pr...
We report the application of quantitative mass spectrometry to identify plasma membrane proteins dif...
PURPOSE: Despite recent approvals for checkpoint inhibitors and antibody-drug conjugates targeting N...
The transmembrane glycoprotein, CUB (complement C1r/C1s, Uegf, Bmp1) domain-containing protein 1 (CD...
CUB Domain Containing Protein 1 (CDCP1) is a transmembrane glycoprotein that has mainly been implica...
Rationale: An antibody-drug conjugate (ADC) is a targeted therapy consisting of a cytotoxic payload ...
Background: CUB domain-containing protein 1 (CDCP1) is a cell surface receptor regulating key signal...
CUB domain-containing protein 1 (CDCP1) is a transmembrane protein that is highly expressed in stem ...
The prognosis of patients with advanced urothelial carcinoma (UC) remains poor and improving treatme...
Elevated CUB-domain containing protein 1 (CDCP1) is predictive of colorectal cancer (CRC) recurrence...
CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a mar...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to le...